Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

May 19, 2022

SwanBio raises $56m to advance new gene therapies for neurological conditions

SwanBio Therapeutics, a gene therapy company, has raised $56m through Series B financing round to advance gene therapies for neurological conditions.

SwanBio raises $56m to advance new gene therapies for neurological conditions